Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

American Society for Gastrointestinal Endoscopy standards for fellowship training in peroral endoscopic myotomy.

Gastrointestinal endoscopy·2026
Same author

Boldly going where no one has gone before: a history of peroral endoscopic myotomy in the United States.

iGIE : innovation, investigation and insights·2026
Same author

ASGE Endoscopy Live: Management of Achalasia. A case of "anti-reflux POEM" in a patient with type II achalasia.

iGIE : innovation, investigation and insights·2026
Same author

Peroral direct diverticulotomy: a salvage peroral endoscopic myotomy technique for patients with "blown-out myotomy".

VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy·2025
Same author

Photo Quiz: Appendiceal agony and hepatic havoc: exploring infection in the immunocompromised.

Journal of clinical microbiology·2025
Same author

Computer-aided detection for esophageal achalasia (with video).

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2025
Same journal

Transform-The Path Forward: Endoscopy and the Science of Expertise.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Ushering in a New Era of Training in Endoscopy.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Where Do We Go from Here: Transforming Teaching Endoscopy Knowledge Using the Expert Performance Approach.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Integrating Artificial Intelligence into Endoscopy Training.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

From Expert to Educator: Translating Expert Performance into Teachable Competencies Through Trainer Development in Endoscopic Simulation.

Gastrointestinal endoscopy clinics of North America·2026
Same journal

Implementing Endoscopy Simulation Nationally.

Gastrointestinal endoscopy clinics of North America·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Achalasia.

Stavros N Stavropoulos1, Rani Modayil, David Friedel

  • 1Division of Gastroenterology, Hepatology and Nutrition, Winthrop University Hospital, Mineola, NY 11501, USA. sstavropoulos@winthrop.org

Gastrointestinal Endoscopy Clinics of North America
|November 22, 2012
PubMed
Summary
This summary is machine-generated.

Achalasia treatment focuses on weakening the lower esophageal sphincter. Newer endoscopic methods like per oral endoscopic myotomy may soon become the standard of care for achalasia.

More Related Videos

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
06:42

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

Related Experiment Videos

Last Updated: May 16, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
06:42

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

Area of Science:

  • Gastroenterology
  • Surgical Innovation

Background:

  • Achalasia is a rare esophageal motility disorder characterized by impaired relaxation of the lower esophageal sphincter (LES).
  • Current therapeutic strategies aim to reduce LES pressure and improve esophageal emptying.

Purpose of the Study:

  • To review the current endoscopic and surgical treatment options for achalasia.
  • To highlight the emerging role of per oral endoscopic myotomy (POEM) in achalasia management.

Main Methods:

  • Review of existing literature on achalasia treatments.
  • Comparison of efficacy and outcomes for surgical myotomy, pneumatic dilation, and botulinum toxin injection.
  • Introduction of per oral endoscopic myotomy as a novel endoscopic approach.

Main Results:

  • Pneumatic dilation offers superior results compared to botulinum toxin injection.
  • Pneumatic dilation outcomes may approach those of surgical myotomy.
  • Per oral endoscopic myotomy represents a significant advancement in endoscopic achalasia therapy.

Conclusions:

  • Endoscopic therapies are central to achalasia management by targeting the LES.
  • Per oral endoscopic myotomy is poised to become a leading treatment modality for achalasia, potentially altering the current treatment landscape.